Approval · Notice of Compliance 5222 · 1995
DIPRIVAN: Notice of Compliance 5222
Issued April 19, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5222
- Date
- April 19, 1995
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use in neurosurgery
- Therapeutic class
- Intravenous emulsion, anesthetic, sedative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPRIVAN | Not yet assigned | — |
Medicinal ingredients
- PROPOFOL 10 MG per ML